Oncolytics Biotech Chair Wayne Pisano To Serve As Interim CEO As Dr. Matt Coffey Looks To Take Medical Leave Of Absence
Oncolytics Biotech Chair Wayne Pisano To Serve As Interim CEO As Dr. Matt Coffey Looks To Take Medical Leave Of Absence
Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, today announced that Matt Coffey, PhD, President and Chief Executive Officer of Oncolytics will take a medical leave of absence, effective immediately. Wayne Pisano, Chair of Oncolytics' Board of Directors, will serve as the interim CEO during Dr. Coffey's absence.
领先的临床阶段公司聚焦于肿瘤免疫治疗的Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) 今日宣布，总裁兼首席执行官Matt Coffey, PhD，即刻起将休医假。Oncolytics董事会主席Wayne Pisano将在Coffey博士缺席期间担任代理CEO一职。
"On behalf of the Board, I would like to wish Matt a swift recovery. In the interim, the Board and I are highly confident in our tenured executive team's ability to continue executing our mission, achieve our strategic priorities, and drive forward our registration-enabling clinical plans for pelareorep, a differentiated and potentially leading immunotherapeutic agent in breast and pancreatic cancers," said Wayne Pisano, Chair of Oncolytics' Board of Directors. "Together, we will continue to deliver on our long-term goals to ultimately bring pelareorep to patients with cancer."
"我代表董事会祝愿Matt迅速康复。在此期间，我们高度信任管理层团队继续执行我们的任务，实现我们的战略重点，并推动我们的登记使能临床计划，为乳腺癌和胰腺癌等潜在免疫治疗产品pelareorep走向全球领袖地位。"Oncolytics董事会主席Wayne Pisano表示。"我们将继续共同实现我们的长期目标，最终将pelareorep带给癌症患者。"
Wayne Pisano, Chair of the Board since 2013, has more than 30 years of experience as a pharmaceutical industry executive and over 12 years of experience in the biotech industry. Mr. Pisano served as the president of VaxInnate, a privately held biotech company, and has served as a Board Director of several biotech companies, including Provention Bio and Altimmune Inc. He served as Chairman of Provention Bio for four years, overseeing the company's acquisition by Sanofi in April 2023.
担任Oncolytics董事会主席自2013年以来，Wayne Pisano是一位拥有30多年制药行业管理经验，并在生物技术行业超过12年的资深管理人士。Pisano先生曾担任一家私营生物技术公司VaxInnate总裁，也曾担任几家生物技术公司的董事，包括Provention Bio和Altimmune Inc。他还担任Provention Bio主席长达四年，监督该公司于2023年4月被赛诺菲安万特收购。
Mr. Pisano is the former President and CEO of Sanofi Pasteur, one of the largest vaccine companies in the world. He is credited with driving Sanofi Pasteur's leadership within the worldwide influenza market, capturing 50% of global sales. He also laid the foundation for the company's global pediatric vaccines strategy and bolstered the Sanofi Pasteur pipeline with the acquisition of Acambis PLC, a biotech based in Boston, in 2008 and Shantha Biotechnics, a highly regarded Indian vaccine company in 2010. Prior to joining Sanofi Pasteur, he spent 11 years with Novartis (formerly Sandoz). He has a bachelor's degree in biology from St. John Fisher University in New York and an MBA from the University of Dayton in Ohio.
Pisano先生曾是世界上最大的疫苗公司之一Sanofi Pasteur的前总裁兼首席执行官。他曾在全球流感市场中推动Sanofi Pasteur的领导地位并占据50%的全球销售份额。他还为公司的全球儿童疫苗策略奠定了基础，并在2008年以及2010年使Sanofi Pasteur的管道增强了通过Boston生物技术公司Acambis PLC和印度顶尖疫苗公司Shantha Biotechnics的收购。他加入Sanofi Pasteur之前在诺华（前桑多士）工作了11年。他拥有纽约圣约翰费舍尔大学的生物学学士学位和俄亥俄州大学戴顿分校的MBA学位。